[1] 李虹,孔志斌.微生物感染及定植在非囊性纤维化支气管扩张症中的研究进展[J].国际呼吸杂志,2017,37(3):232-235.
[2] Shan K,Ferastraoaru D,J ariwala S.Eosinophilia associated with Strongyloides infection,severe asthma,and central bronchiectasis [J].Ann Allergy Asthma Immunol,2017,118(4):510-511.
[3] 黄阳,戴新建,郑纪阳,等.血清前白蛋白检测在支气管扩张伴感染患者中的意义[J].浙江医学,2014,36(21):1804-1805.
[4] 成人支气管扩张症诊治专家共识编写组.成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志,2012,35(7):485-492.
[5] 周亚光.营养风险筛查方法简介(NRS2002)[J].内科急危重症杂志,2010,16(2):106-110.
[6] 郑劲平.肺通气功能障碍严重程度的分级[J].中华结核和呼吸杂志,2009,32(4):316-318.
[7] 华晨,刘励军.早期肠内营养在危重症病人营养支持中的临床价值[J].肠内与肠外营养,2011,18(1):12-14.
[8] Wells TJ,Davison J,Sheehan E,et al.The use of plasmapheresis in patients with bronchiectasis with pseudomonas aeruginosa infection and inhibitory antibodies [J].Am J Respir Crit Care Med,2017,195(7):955-958.
[9] Eusebio N,Amorim AA,Gamboa F,et al.Molecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis [J].Pathog Dis,2015,3(2):1-7.
[10] Olvira C,Olveira G,Espildora F,et al.Mediterranean diet is associated on symptoms of depression and anxiety in patients with bronchiectasis [J].Gen Hosp Psychiatry,2014,36(3):277-283.
[11] 陈刚,徐永芳,徐长青,等.哌拉西林/他唑巴坦联合依替米星治疗支气管扩张患者感染疗效的分析[J].中华医院感染学杂志,2016,26(9):1970-1972.
[12] Bruu LD,Rogers GB,Chen AC,et al.Macrolide treatment inhibits pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis.an analysis from the bronchiectasis and low-dose erythromycin study trial [J].Ann Am Thorac Soc,2016,13(10):1697-1703.
[13] 徐向英,鞠贞会,王艳萍,等.门诊强化教育对支气管扩张症患者生活质量和运动能力的影响[J].护理学杂志,2015,30(9):23-26.
[14] 张荣蒌,于建梅,鞠贞会,等.家庭营养干预对28例营养不良支气管扩张症患者的影响[J].中国初级卫生保健,2016,30(4):91-92.
[15] 伏冉,郑玉龙,王贻,等.全面肺康复治疗对中、重度慢性阻塞性肺疾病患者稳定期肺功能和血气指标的影响[J].中华物理医学与康复杂志,2016,38(8):594-597.
[16] 杜毓锋,罗潇,钱力,等.整蛋白型肠内营养剂对老年稳定期慢性阻塞性肺疾病患者营养干预的实验研究[J].中国医药,2014,9(10):1451-1455. |
2018, Vol. 35 
